Clinical Trial Update: Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE) [Phase 2]

View source ↗

Summary

Phase 2 imaging study of XERECEPT for peritumoral brain edema and brain tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Malignant Brain Tumor
• Peritumoral Brain Edema

Drugs mentioned

• XERECEPT (human corticotropin-releasing factor)

Snippet

Sponsor: PharmaNet | Conditions: Peritumoral Brain Edema, PRIMARY MALIGNANT and METASTATIC BRAIN TUMORS | Phase 2 | Status: TERMINATED